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Introduction Meningioma recurrence remains a clinical dilemma [1]. There is a marked 
range in the variation amongst surgeons in the follow-up arrangements for their patients even 
within the same unit. This dilemma comes with a price. It has a significant clinical, logistical 
and huge financial implication. Hence, the search for predictors for meningioma recurrence 
has become an increasingly urgent research topic in recent years. 
 
Objective Using spectrochemical analytical methods such as attenuated total reflection 
Fourier-transform infrared (ATR-FTIR) spectroscopy, our primary objective is to compare 
the spectral fingerprint signature of WHO grade I meningioma vs. WHO grade I meningioma 
that recurred. Secondary objectives compare WHO grade I meningioma vs. WHO grade II 
meningioma and WHO grade II meningioma vs. WHO grade I meningioma recurrence. 
  
Materials and Methods Our selection criteria included convexity meningioma only 
restricted to Simpson grade I & II only and WHO grade I & grade II only with a minimum 5 
years follow up. With appropriate ethics, we obtained tissue from tumour blocks retrieved 
from the Brain Tumour NorthWest (BTNW) biobank. These were sectioned onto slides and 
de-waxed prior to ATR-FTIR or Raman spectrochemical analysis. Derived spectral datasets 
were then explored for discriminating features using computational algorithms in the 
IRootLab toolbox within MATLAB [2]; this allowed for classification and feature extraction.   
 
Results After analysing the data using various classification algorithms such as PCA-LDA or 
SVM with cross-validation to avoid over-fitting of the spectral data, we can readily and 
blindly segregate those meningioma samples that recurred from those that did not recur in the 
follow-up timeframe. The forward feature extraction classification algorithms generated 
results that exhibited excellent sensitivity and specificity, especially with spectra obtained 
following ATR-FTIR spectroscopy. Our secondary objectives remain to be fully developed. 
 
Discussion We demonstrate a reagent-free, non-destructive and low-cost tool that could give 
predictive information regarding the propensity of a meningioma to recur. This has enormous 
clinical potential with regards to being developed for intra-operative real-time assessment of 
disease. 
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